Get in Touch
Use the form below to send us a message.
We typically respond within 7 business days.
What We Can Help With
This form is for questions about our published content, not for medical, sourcing, or access-related questions.
Content Questions
- Requests for citations or clarification about clinical trial data referenced in our articles
- Requests to update an article when new peer-reviewed or publicly reported information becomes available
- Questions about how our articles describe differences between retatrutide and other investigational compounds discussed in the research literature
Website Issues
- Reporting broken links or technical problems
- Suggesting topics for future articles
- Flagging content that appears outdated
Privacy & Data Requests
- Unsubscribing from our newsletter
- Requesting deletion of your information (GDPR/CCPA rights)
- Questions about how we handle your data
Corrections
- Reporting factual errors or inaccuracies in our content
- Providing published sources or context we may have missed
What We Cannot Help With
Medical Advice: We cannot provide personalized medical advice, treatment recommendations, or diagnoses. For health concerns, please consult a licensed physician.
Access or Sourcing: Retatrutide is investigational and not approved by the FDA or any other regulatory body for any use. We do not help visitors obtain, source, or access retatrutide or any other medication.
Clinical Trial Enrollment: We do not run clinical trials and cannot enroll participants. Visit ClinicalTrials.gov to search for trials currently accepting participants.
Pricing or Insurance: We do not track or report pricing, insurance coverage, or supplier information for investigational compounds.
Privacy Notice
Messages submitted through this form are handled according to our Privacy Policy. We collect only the information necessary to respond to your inquiry and do not share your contact information with third parties.
We do not maintain a waitlist. If you'd like to be notified when we publish new articles, you're welcome to subscribe to our newsletter.
Response Time: We aim to respond to inquiries within 7 business days.